Seng P, Vernier M, Gay A, Pinelli P-O, Legré R, Stein A
Centre de Référence des Infections Ostéo-Articulaires (CRIOA) Interrégional Sud-Méditerranée, Service des Maladies Infectieuses, Hôpital de la Conception, Marseille, France; Aix-Marseille Université, URMITE, UM 63, CNRS 7278-IRD 198, INSERM 1095, Faculté de Médecine, Marseille, France.
Service de chirurgie réparatrice, Hôpital de la Timone, Marseille, France.
New Microbes New Infect. 2016 Apr 13;12:8-17. doi: 10.1016/j.nmni.2016.03.009. eCollection 2016 Jul.
Streptococcal bone and joint infections are less common than staphylococcal cases. Few studies have reported the cases with well-identified Streptococcus species. Their clinical features and prognosis are not clearly known to date. Moreover, no treatment regimen has yet been clarified. We reviewed the streptococcal bone and joint infection cases managed in our centres from January 2009 to December 2013. We described the epidemiology, clinical and microbiologic characteristics, treatment approach and outcome. Among the 93 cases, 83% of patients were men with a median age of 60 years, and 90% of patients had comorbidities or risk factors. Bacteraemia occurred in 14% of cases. Serious complications occurred in six patients, including severe sepsis (two cases) and infective endocarditis (two cases). Orthopaedic device infections were observed in 35% of cases, including 17 patients with internal osteosynthesis device infection, 14 with prosthetic joint infection and three with vertebral osteosynthesis device infection. The median time between orthopaedic device implantation and onset of infection was 447 days. Fourteen species of Streptococcus were identified, including 97 isolates using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and three isolates using molecular identification. The five most represented species included S. agalactiae (37%), S. dysgalactiae (12%), S. anginosus (11%), S. constellatus (10%) and S. pneumoniae (9%). Streptococci isolates were susceptible to amoxicillin, with the exception of one S. mitis isolate. Remission 1 year after the end of treatment was recorded in 83%. One patient died of infection; eight patients had infections that failed to respond to treatment; and seven patients experienced relapse. Twenty patients (22%) had an unfavourable functional outcome, including 19 amputations and one arthrodesis. Five significant prognostic factors associated with an unfavourable clinical outcome were identified, including peripheral neuropathy (p 0.009), peripheral arterial disease (p 0.019), diabetes mellitus (p 0.031), location in the femur (p 0.0036), location in the foot (p 0.0475), osteitis without an orthopaedic device (p 0.041) and infection caused by S. dysgalactiae (p 0.020). The rate of poor outcomes remains high despite the low number of Streptococcus isolates resistant to antibiotics. Some prognostic factors, such as the presence of S. dysgalactiae, are associated with an unfavourable clinical outcome. Antibiotic regimens of streptococcal bone and joint infections are not standardized and need to be further investigated.
链球菌性骨与关节感染比葡萄球菌性病例少见。很少有研究报道明确鉴定出链球菌种类的病例。迄今为止,它们的临床特征和预后尚不清楚。此外,尚无明确的治疗方案。我们回顾了2009年1月至2013年12月在我们中心治疗的链球菌性骨与关节感染病例。我们描述了其流行病学、临床和微生物学特征、治疗方法及结果。在93例病例中,83%的患者为男性,中位年龄为60岁,90%的患者有合并症或危险因素。14%的病例发生了菌血症。6例患者出现严重并发症,包括严重脓毒症(2例)和感染性心内膜炎(2例)。35%的病例观察到骨科器械感染,其中17例为内固定器械感染,14例为人工关节感染,3例为椎体固定器械感染。骨科器械植入与感染发生之间的中位时间为447天。鉴定出14种链球菌,其中97株采用基质辅助激光解吸/电离飞行时间质谱法鉴定,3株采用分子鉴定法鉴定。最常见的5种菌种包括无乳链球菌(37%)、停乳链球菌(12%)、咽峡炎链球菌(11%)、星座链球菌(10%)和肺炎链球菌(9%)。除1株缓症链球菌分离株外,链球菌分离株对阿莫西林敏感。治疗结束1年后,83%的患者病情缓解。1例患者死于感染;8例患者感染治疗无效;7例患者复发。20例患者(22%)功能预后不良,包括19例截肢和1例关节融合术。确定了5个与不良临床结局相关的重要预后因素,包括周围神经病变(p = 0.009)、外周动脉疾病(p = 0.019)、糖尿病(p = 0.031)、股骨部位(p = 0.0036)、足部部位(p = 0.0475)、无骨科器械的骨炎(p = 0.041)以及停乳链球菌引起的感染(p = 0.020)。尽管对抗生素耐药的链球菌分离株数量较少,但不良结局的发生率仍然很高。一些预后因素,如停乳链球菌的存在,与不良临床结局相关。链球菌性骨与关节感染的抗生素治疗方案尚未标准化,需要进一步研究。